BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23415237)

  • 1. Prognostic significance of vascular and lymphatic emboli in resected pulmonary adenocarcinoma.
    Strano S; Lupo A; Lococo F; Schussler O; Loi M; Younes M; Bobbio A; Damotte D; Regnard JF; Alifano M
    Ann Thorac Surg; 2013 Apr; 95(4):1204-10. PubMed ID: 23415237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.
    Cox ML; Yang CJ; Speicher PJ; Anderson KL; Fitch ZW; Gu L; Davis RP; Wang X; D'Amico TA; Hartwig MG; Harpole DH; Berry MF
    J Thorac Oncol; 2017 Apr; 12(4):689-696. PubMed ID: 28082103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic Findings and Long-Term Results After Surgical Treatment for Pulmonary Sarcomatoid Tumors: A Multicenter Analysis.
    Lococo F; Rapicetta C; Cardillo G; Stefani A; Margaritora S; Leuzzi G; Rossi G; Petracca Ciavarella L; Morandi U; Facciolo F; Ricchetti T; Cesario A; Paci M
    Ann Thorac Surg; 2017 Apr; 103(4):1142-1150. PubMed ID: 28027731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral lymphatic vessel involvement is an invasive indicator of completely resected pathologic stage I non-small cell lung cancer.
    Harada M; Hato T; Horio H
    J Thorac Oncol; 2011 Jan; 6(1):48-54. PubMed ID: 21079523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.
    Mansuet-Lupo A; Bobbio A; Blons H; Becht E; Ouakrim H; Didelot A; Charpentier MC; Bain S; Marmey B; Bonjour P; Biton J; Cremer I; Dieu-Nosjean MC; Sautès-Fridman C; Régnard JF; Laurent-Puig P; Alifano M; Damotte D
    Chest; 2014 Sep; 146(3):633-643. PubMed ID: 24676429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
    Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic prognostic factors in resected colorectal lung metastases.
    Shiono S; Ishii G; Nagai K; Yoshida J; Nishimura M; Murata Y; Tsuta K; Nishiwaki Y; Kodama T; Ochiai A
    Ann Thorac Surg; 2005 Jan; 79(1):278-82; discussion 283. PubMed ID: 15620957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients after lobectomy for p-T1aN0M0 adenocarcinoma.
    Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Ishikawa S; Yokomise H
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):603-6. PubMed ID: 22345182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobectomy with pulmonary artery resection: morbidity, mortality, and long-term survival.
    Alifano M; Cusumano G; Strano S; Magdeleinat P; Bobbio A; Giraud F; Lebeau B; Régnard JF
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1400-5. PubMed ID: 19464456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification.
    Samejima J; Yokose T; Ito H; Nakayama H; Nagashima T; Suzuki M; Hamanaka R; Yamada K; Masuda M
    Lung Cancer; 2019 Nov; 137():144-148. PubMed ID: 31593845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of survival in 400 surgically resected non-small cell lung carcinomas: towards a redefinition of the T factor.
    Lyons G; Quadrelli S; Silva C; Vera K; Iotti A; Venditti J; Chertcoff J; Chimondeguy D
    J Thorac Oncol; 2008 Sep; 3(9):989-93. PubMed ID: 18758301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma.
    Mimae T; Tsutani Y; Miyata Y; Yoshiya T; Ibuki Y; Kushitani K; Takeshima Y; Nakayama H; Okumura S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1820-6. PubMed ID: 24507979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.
    Warwick R; Mediratta N; Shackcloth M; Page R; McShane J; Shaw M; Poullis M
    Asian Cardiovasc Thorac Ann; 2013 Oct; 21(5):566-73. PubMed ID: 24570559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited commentary.
    Lin SH
    Ann Thorac Surg; 2013 Apr; 95(4):1210-1. PubMed ID: 23522192
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary fissure development is a prognostic factor for patients with resected stage I lung adenocarcinoma.
    Lee S; Lee JG; Lee CY; Kim DJ; Chung KY
    J Surg Oncol; 2016 Dec; 114(7):848-852. PubMed ID: 27633283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.
    Funai K; Sugimura H; Morita T; Shundo Y; Shimizu K; Shiiya N
    Ann Surg Oncol; 2011 Oct; 18(10):2968-72. PubMed ID: 21512862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.
    Thorsteinsson H; Alexandersson A; Oskarsdottir GN; Skuladottir R; Isaksson HJ; Jonsson S; Gudbjartsson T
    J Thorac Oncol; 2012 Jul; 7(7):1164-9. PubMed ID: 22592213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.